← Eichor
Study identifier: NCT05300893 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture

Condition: Dupuytren Contracture · Dupuytren's Disease  ·  Sponsor: Uppsala University

PhaseNA
Planned participants154
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Dupuytren's contracture (DC) is associated with progressive finger flexion and extension deficit caused by fibrosis in the palm and digits. Treatment options include minimally invasive procedures such as percutaneous needle fasciotomy (PNF) and collagenase clostridium histolyticum injections as well as open fasciectomy. PNF has recently become more popular in Sweden because it is an office-based procedure which is relatively easy to perform without the usual risks and costs of open surgery. After treatment with PNF patients usually continue with supervised rehabilitation, which includes physical therapy and night splinting. Whether night splinting is beneficial in terms of reducing recurrence of DC is currently debated. This study aims to investigate whether night splinting after performed PNF helps to reduce recurrence rate or not. Patients who meet the inclusion criteria will be randomized into two groups: The first group will be treated as usual with physical therapy and night splinting after PNF. The second group will be treated with physical therapy without night splinting after PNF. Follow up includes physical examination regarding active range of motion, sensation and grip strength at procedure day and 2 weeks, 3, 12 and 36 months later as well as questionnaires regarding hand function, pain and quality of life at procedure day and 3, 12 and 36 months later. Patients who are randomized into the second group (no night splinting) will also be examined 3 weeks after PNF…

This description comes directly from the study's public registry record.

Talk to the study team

Daniel Muder, MD  ·  0046-23-490000  ·  daniel.muder@surgsci.uu.se

Antje Straatmann, MD  ·  0046-18-6110000  ·  antje.straatmann@akademiska.se

Always discuss trial participation with your own doctor first.

Locations (3)

Falu LasarettFalun, Dalarna County, SwedenRecruiting
Akademiska SjukhusetUppsala, Uppsala County, SwedenRecruiting
Universitetssjukhuset ÖrebroÖrebro, Örebro County, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05300893